Aranda's R&D programs
Aranda Pharma is dedicated to discover and develop novel small molecules to treat diseases of elderly with high unmet medical needs. Our research programs center on finding better treatment options for patients with advanced prostate cancer or neurodegenerative diseases. Aranda’s small molecule R&D programs originate from Medeia Therapeutics’s drug discovery pipeline.
All Aranda’s research programs are IP secured and contain parallel back-up programs.